Journal for ImmunoTherapy of Cancer (Nov 2023)
1232 PBMC humanized mouse model with clinical relevance in assessing the safety profile of 4–1BB agonist, urelumab, in 5 donors
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)